WELL BEING STUDY
Investigators
at the Western Psychiatric Institute & Clinic, UPMC, Pittsburgh are
conducting a 26-week research study to examine the effectiveness of using a low
dose FDA approved cholesterol lowering medication to improve your enjoyment of
everyday activities, ability to focus, motivation, sociability, mood and general
well being.
Participation
in this study requires 7 blood draws, an EKG (paper tracing of the electrical
activity of the heart) and psychiatric testing.
To be considered for this study, you must be:
 |
18 to 65 Years old. |
|
|
Have a diagnosis of
Schizophrenia or Schizoaffective Disorder |
|
|
Be currently receiving a stable dose of only one antipsychotic medication |
|
|
Not
had a psychiatric hospitalization in the past 60 days |
You
will receive $300 for your participation in this study
If interested, please call 800-416-4286